Read article – A news brief about a new program called Qmmunity, which looks to pair Dartmouth medical students as mentors with LGBTQ youth in the Upper Valley. Qmmunity is a collaboration between the Geisel School of Medicine and the group Rural Outright. (Similar coverage in Kaiser Health News.)

Read article – Quotes Ellen Meara, professor of The Dartmouth Institute for Health Policy and Clinical Practice and adjunct professor in economics, in an article about how drug overdoses and suicides are causing American life expectancy to drop. “Sadly, this result confirms what many suspected based on data coming out earlier this year, that we continue to lose ground due in large part to preventable causes of death like overdose, suicide, and from deaths due to chronic lower respiratory diseases, many of which are attributable to tobacco use,” says Meara.

Read article – Richard Rothstein, the Joseph M. Huber Professor and chair of medicine, recently attended Obesity Week 2018 to present the results from the nine-site ENDOBesity II study of a novel investigational weight-loss device called the TransPyloric Shuttle. The study found that the device was safe and effective in a 12-month, phase 3 pivotal trial.

Read article – An article remembering the life of Barbara Blough, MALS ’74, who provided more than 50 years of enthusiastic public service to the Upper Valley community. The article mentions that Blough was the founding director of alumni affairs at the Geisel School of Medicine (known as Dartmouth Medical School at the time), where she raised funds for the school, created the alumni magazine, and started the school’s first alumni program — all of which required passionate, persuasive outreach. The medical school recognized her 15 years of service with a conference room in her name.

Read article – Cites comments by Steven Woloshin, professor of The Dartmouth Institute for Health Policy and Clinical Practice, medicine, and community and family medicine, in an article about biopharma company Amarin’s claims that its clinical trial results for the Vascepa show that it could transform heart disease prevention. Woloshin noted that the trial focused on patients who had high triglyceride levels, a history of heart disease or another elevated risk, and were already taking statins, meaning that the benefits of the drug are focused on a specific population.

Read article – Cites comments by Steven Woloshin, professor of The Dartmouth Institute for Health Policy and Clinical Practice, medicine, and community and family medicine, in an article about biopharma company Amarin’s claims that its clinical trial results for the Vascepa show that it could transform heart disease prevention. Woloshin noted that the trial focused on patients who had high triglyceride levels, a history of heart disease or another elevated risk, and were already taking statins, meaning that the benefits of the drug are focused on a specific population.

Read article – Quotes Samir Soneji, associate professor of The Dartmouth Institute for Health Policy and Clinical Practice, in an article about the Food and Drug Administration’s (FDA) recently proposed sweeping new restrictions on the sale of e-cigarettes in an effort to cut down on teenage vaping. The agency also said it would seek to ban menthol-flavored traditional cigarettes and flavored cigars. “If the vaping industry is serious, there’s no reason for Juul to sell watermelon, mint or fruit medley … because it attracts kids and we’re starting to learn it doesn’t appeal to adult smokers,” says Soneji.

Read article – Quotes Marcus Shaker, associate professor of pediatrics and of community and family medicine, about new cost-effectiveness analysis research he led to find the maximum price tag that the medical industry can hang on self-injectable epinephrine autoinjectors.

Read article – Themarge Small, clinical assistant professor of obstetrics and gynecology, recently joined the Southwestern Vermont Health Care Foundation board of directors.

Read article – A segment about a pilot program in the Upper Valley that sends paramedics into people’s homes before they need to go to the hospital. Doctors say it fills a crucial void that could ultimately lead to lower costs in healthcare. The Community Paramedic Program was created two years ago by medical students at the Geisel School of Medicine in partnership with Dartmouth-Hitchcock’s Lyme clinic.